CompletedPhase 3NCT03208179

Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Liverpool School of Tropical Medicine
Principal Investigator
Simon K Kariuki, PhD
Kenya Medical Research Institute
Intervention
dihydroartemisinin-piperaquine(drug)
Enrollment
4680 target
Eligibility
16 years · FEMALE
Timeline
2018 – 2020

Study locations (7)

Collaborators

Kamuzu University of Health Sciences · Kenya Medical Research Institute · Malawi-Liverpool-Wellcome Trust Clinical Research Programme · National Institute for Medical Research, Tanzania · Kilimanjaro Christian Medical Centre, Tanzania · University of Copenhagen · Centers for Disease Control and Prevention · London School of Hygiene and Tropical Medicine · University College, London · Tampere University · University of Bergen · University of Massachusetts, Worcester · University of Toronto · University of Melbourne · Foundation for Innovative New Diagnostics, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03208179 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials